| Bilal Piperdi, MD | |
|
55 Lake Ave N, Department Of Hematology/oncology, Worcester, MA 01655-0002 | |
| (508) 856-3933 | |
| Not Available |
| Full Name | Bilal Piperdi |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine - Hematology & Oncology |
| Location | 55 Lake Ave N, Worcester, Massachusetts |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1063495901 | NPI | - | NPPES |
| 2041481 | Medicaid | MA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RH0003X | Internal Medicine - Hematology & Oncology | 220484 (Massachusetts) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Bilal Piperdi, MD Po Box 415348, Boston, MA 02241-5348 Ph: () - | Bilal Piperdi, MD 55 Lake Ave N, Department Of Hematology/oncology, Worcester, MA 01655-0002 Ph: (508) 856-3933 |
News Archive
Reduced-intensity conditioning reduces toxicity associated with allogeneic hematopoietic cell transplantation for acute myeloid leukemia without affecting long-term outcomes, show results from the first randomized trial of this treatment.
Cancer Treatment Centers of America (CTCA) at Midwestern Regional Medical Center (Midwestern) has been recognized by the National Quality Measures for Breast Centers Program (NQMBC) as being among the top centers in the country for providing quality breast cancer care.
Lexicon Pharmaceuticals, Inc., today reported financial results for the second quarter ended June 30, 2015 and provided an overview of key milestones for the company's lead drug candidates.
Codexis, Inc. today announced an expansion of its relationship and the signing of its second agreement this year with Teva Pharmaceutical Industries Ltd., the world's largest generic drug manufacturer. The new agreement covers three undisclosed pharmaceutical products.
Bristol-Myers Squibb Company today announced results from a Phase 2 and a Phase 1b study of its investigational PD-1 immune checkpoint inhibitor nivolumab in patients with advanced or metastatic renal cell carcinoma (RCC), commonly known as kidney cancer.
› Verified 4 days ago
Dr. Adepeju Gbadebo Champion, M.D. Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 55 Lake Ave N, Worcester, MA 01655 Phone: 508-334-2731 Fax: 774-442-4672 | |
Madaiah Lokeshwari, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 123 Summer St, Worcester, MA 01608 Phone: 508-363-6849 | |
Sowmya Korapati, Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 55 Lake Ave N, Worcester, MA 01655 Phone: 508-334-3550 Fax: 774-442-6715 | |
Irma Hashmi, DO Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 55 Lake Ave N, Worcester, MA 01655 Phone: 508-334-1000 | |
Dr. Madhav Sharma, MD Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 123 Summer St, Worcester, MA 01608 Phone: 508-363-5438 | |
Daniel M Steigman, MD Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 123 Summer Street, Suite 390, Worcester, MA 01608 Phone: 508-368-3120 Fax: 508-368-3121 | |
Dr. Julia D Andrieni, M.D. Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 55 Lake Ave N, Department Of General Medicine, Worcester, MA 01655 Phone: 508-334-2731 |